Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13851ApprovedSmall molecule
Artemotil, also known as β-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria...
- Formula / weight
- C17H28O5 · 312.406 g/mol (avg)
- Also known as
- Arteether · beta-Arteether · beta-Dihydroartemisinin ethyl ether · Dihydroartemisinin ethyl ether
- Code names
- SM 227
Resolves to
Clinical / RWD
Structure
InChIKey
NLYNIRQVMRLPIQ-XQLAAWPRSA-NSMILES[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@H](OCC)[C@@H]2C)O4Targets
What you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Artemotil, and which of those have an active Phase 3 trial?